hallucinations phenotype

Aliases: hallucinations item

Evidence from: primary | all sources

Related entities (12)

Subject	Relation	Object	p-value	Evidence
adolescent cannabis use	risk_factor_for	hallucinations	—	1
cannabinoids	associated_with	hallucinations	—	1
cannabis use	risk_factor_for	hallucinations	—	2
COMT Val allele	risk_factor_for	hallucinations	—	1
hallucinations	associated_with	psychiatric disorders	—	1
LSD	associated_with	hallucinations	—	1
normal controls	associated_with	hallucinations	—	1
positive symptoms	associated_with	hallucinations	—	1
rs2075572	associated_with	hallucinations	—	1
schizophrenia	associated_with	hallucinations	—	1
schizophrenia polygenic risk score	associated_with	hallucinations	—	1
Δ9-THC	associated_with	hallucinations	—	1

Mentioned in (21)

Papers in which this entity is mentioned.

DNA methylation at birth and lateral ventricular volume in childhood: a neuroimaging epigenetics study. (2024)
Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
Social cognition as an RDoC domain. (2016)
The PsychENCODE project. (2015)
Pharmacogenetics of OPRM1. (2014)
Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
Cannabis controversies: how genetics can inform the study of comorbidity. (2014)
Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
Rethinking schizophrenia in the context of normal neurodevelopment. (2013)
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. (2012)
Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. (2012)
Classification of neurocognitive disorders in DSM-5: a work in progress. (2011)
Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence. (2011)
Psychiatric comorbidity in methamphetamine dependence. (2011)
Corpus callosum abnormalities and their association with psychotic symptoms in patients with schizophrenia. (2010)
Cannabis and psychosis/schizophrenia: human studies. (2009)
On the value of homogeneous constructs for construct validation, theory testing, and the description of psychopathology. (2009)
An exploration of attitudes among black Americans towards psychiatric genetic research. (2009)
EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. (2008)
Cannabis withdrawal in the United States: results from NESARC. (2008)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.

Raw name	Type	Papers	Mentions
hallucinations	phenotype	21	41
hallucinations item	phenotype	—	—